Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Hirotaka Numaguchi"'
Autor:
Kazuhiro Hashiguchi MD, Kimihiro Okubo MD, PhD, Yoichi Inoue MD, Hirotaka Numaguchi MD, PhD, Kumi Tanaka MS, Nobuyuki Oshima MS, Anish Mehta BA, Chisato Nishida MS, Itori Saito MS, George Philip MD
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Background This study evaluated the efficacy of montelukast in reducing seasonal allergic rhinitis symptoms in Japanese children with Japanese cedar (JC) pollinosis induced in an artificial exposure chamber (OHIO Chamber). Methods Pediatric patients
Externí odkaz:
https://doaj.org/article/90d6093b7fe444c4afbf854f42e421fa
Autor:
Yumi Tsuchiya, Hiroshi Tamura, Koji Fujii, Hirotaka Numaguchi, Kiichiro Toyoizumi, Tina Liu, Mathieu Le Gars, Vicky Cárdenas, Takashi Eto
Publikováno v:
Vaccine. 41:1602-1610
Autor:
Hidenori Arai, Tamio Teramoto, Robert O. Blaustein, Mariko Nakagomi, Katsunori Ikewaki, Hiroyuki Daida, Hirotaka Numaguchi, Masayoshi Shirakawa, Yuichiro Watanabe, Amy O. Johnson-Levonas, Taro Kakikawa, Yuko Maeda
Publikováno v:
Atherosclerosis. 261:69-77
We aimed to assess the effects of cholesteryl ester transfer protein inhibitor anacetrapib added to statin ± other lipid-modifying therapies (LMT) in Japanese patients with dyslipidemia who were not at their LDL-C goal.Patients on a stable dose of s
Autor:
Mariko Nakagomi, Hidenori Arai, Hiroyuki Daida, Masayoshi Shirakawa, Hirotaka Numaguchi, Sanskruti Vaidya, Taro Kakikawa, Yuko Maeda, Amy O. Johnson-Levonas, Tamio Teramoto, Katsunori Ikewaki, Robert O. Blaustein
Publikováno v:
Atherosclerosis. 249:215-223
This multicenter, randomized, double-blind, placebo-controlled study assessed the lipid-modifying efficacy/safety profile of anacetrapib 100 mg added to ongoing statin ± other lipid-modifying therapies (LMT) in Japanese patients with heterozygous fa
Autor:
Yuki Matsumoto, Itori Saito, Kimihiro Okubo, Nobuyuki Oshima, Marita Prohn, Kumi Tanaka, Hirotaka Numaguchi, Chisato Nishida, George Philip, Anish Mehta, Yoichi Inoue
Publikováno v:
Journal of Drug Assessment
Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67840412cedf2c06aeb4d437af4a730
Autor:
Hirotaka Numaguchi, Kimihiro Okubo, Itori Saito, Kazuhiro Hashiguchi, Chisato Nishida, Yoichi Inoue, George Philip, Nobuyuki Oshima, Anish Mehta, Kumi Tanaka
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Background This study evaluated the efficacy of montelukast in reducing seasonal allergic rhinitis symptoms in Japanese children with Japanese cedar (JC) pollinosis induced in an artificial exposure chamber (OHIO Chamber). Methods Pediatric patients
Autor:
Kazuyuki Shimada, Kenji P Fujita, Hiromi Rakugi, Hiroya Yamaguchi, Hirotaka Numaguchi, Chisato Nishida, Masayoshi Shirakawa, Kyoichi Azuma, Takuya Tsuchihashi
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 37(3)
Japanese patients with uncontrolled essential hypertension received single-blind losartan 50 mg/hydrochlorothiazide 12.5 mg (L50/H12.5) for 8 weeks. Patients whose blood pressure (BP) remained uncontrolled were randomized double-blind to fixed-dose l
Autor:
Yoshito Koseki, Jun Watanabe, Tsuyoshi Shinozaki, Masahito Sakuma, Tatsuya Komaru, Mitsumasa Fukuchi, Masahito Miura, Akihiko Karibe, Yuji Kon-no, Hirotaka Numaguchi, Mototsugu Ninomiya, Yutaka Kagaya, Kunio Shirato, null the CHART Investigators
Publikováno v:
Circulation Journal. 67:431-436
The study was designed to characterize patients with chronic heart failure (CHF) in Japan in terms of the etiologies and prognosis. CHF was defined by ejection fraction (EF ≥50%), left ventricular diastolic dimension (LVDD ≥55 mm) or a past histo
Autor:
Tadashi Sugie, Tsuyoshi Shinozaki, Mototsugu Ninomiya, Mitsumasa Fukuchi, Kimio Sato, Hirotaka Numaguchi, Junichi Kikuchi, Takanori Takahashi, Kohei Fukahori, Kunio Shirato, Hiroko Tada, Akihiko Karibe, Hideaki Endo, Jun Otomo, Masanori Hirose, Yuji Wakayama, Masahito Miura, Jun Watanabe
Publikováno v:
Japanese Journal of Electrocardiology. 23:606-613
アミオダロン (AMD) が慢性心不全患者の左室収縮能に与える効果を検討した.頻脈性不整脈の治療目的にAMDが投与され, かつβ遮断薬を使用しなかった慢性心不全患者のうち, AMD投与後6カ月
Autor:
Kunio Shirato, Jun Watanabe, Tsuyoshi Shinozaki, Hironori Odakura, Tadashi Sugie, Hiroko Tada, Masahito Miura, Takanori Takahashi, Koichi Tabayashi, Koji Kumagai, Jun Ohtomo, Kohei Fukahori, Hirotaka Numaguchi, Yoshinao Sugai, Mitsumasa Fukuchi, Masanori Hirose
Publikováno v:
Japanese Journal of Electrocardiology. 22:653-657